Niagen Bioscience can either commercialise the drug candidate independently or sublicense to a strategic pharmaceutical ...

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

NVO submits higher-dose Wegovy to EMA, aiming for greater weight loss and stronger defense against rivals in the obesity ...

Lupin and Zentiva partner to commercialize Certolizumab Pegol biosimilar globally, sharing profits and investing in ...

This article summarizes recent health news, covering a spectrum of global issues. Highlights include Brazil's avian flu trade ...

GMP manufacturing completed, paediatric waiver granted, positive outcome from FDA and EMA interactions; advancing mitazalimab toward Phase 3 readinessBiomarker data from OPTIMIZE-1 presented at ASCO, ...

Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial Recent EU approval from the European Medicines Agency (EMA) boosts ...

Finland’s medicines agency Fimea warns of a surge in online scam ads falsely claiming official approval for health products.

An announcement from Moleculin Biotech ( ($MBRX) ) is now available. On July 9, 2025, Moleculin Biotech announced that the Regulation Agency for ...

Lilly's Kisunla gets FDA approval for a new dosing schedule that significantly lowers ARIA-E risk while maintaining amyloid ...

Danish drugmaker Novo Nordisk (NOV: N) has filed for European approval of a higher-dose version of its obesity treatment ...

Recent health news includes trade restrictions on Brazilian chicken due to bird flu, potential U.S. tariffs on ...